Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2010 Sep 3;7(3):271-2.
doi: 10.1016/j.stem.2010.08.008.

Cancer cell of origin: spotlight on luminal progenitors

Affiliations
Comment

Cancer cell of origin: spotlight on luminal progenitors

Christine L Chaffer et al. Cell Stem Cell. .

Abstract

Does basal type breast cancer arise from oncogenic transformation of a basal cell type? In this issue Molyneux and colleagues investigate the provenance of the basal-type BRCA1 breast carcinoma and come up with unanticipated results.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Schematic diagram of a mammary stem cell hierarchy
In this diagram, a luminal ER- progenitor cell (CD24+/HighSca1-ER-) acquires a BRCA1 mutation and subsequently transitions into an aberrant basal progenitor cell (or directly differentiates into aberrant basal –like cells) and thus gives rise to BRCA1- mutant basal-like breast carcinoma. It is also possible that luminal ER- progenitor cells can transdifferentiate into basal progenitor cells as part of a normal physiological process, either directly (depicted by arrow with a question mark) or first via dedifferentiation to a common progenitor/stem cell

Comment on

References

    1. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. Identification of a cell of origin for human prostate cancer. Science. 2010;329:568–571. - PMC - PubMed
    1. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A, et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med. 2009;15:907–913. - PubMed
    1. Liu S, Ginestier C, Charafe-Jauffret E, Foco H, Kleer CG, Merajver SD, Dontu G, Wicha MS. BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci U S A. 2008;105:1680–1685. - PMC - PubMed
    1. Liu X, Holstege H, van der Gulden H, Treur-Mulder M, Zevenhoven J, Velds A, Kerkhoven RM, van Vliet MH, Wessels LF, Peterse JL, et al. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc Natl Acad Sci U S A. 2007;104:12111–12116. - PMC - PubMed
    1. Petersen OW, Polyak K. Stem cells in the human breast. Cold Spring Harb Perspect Biol. 2010;2:a003160. - PMC - PubMed